The February 2025 issue of the Journal of Drugs in Dermatology brings a fresh wave of clinical insights and innovative research to the dermatology community. This edition highlights new perspectives on minoxidil adherence, groundbreaking findings in keloid and hypertrophic scar risk factors, and expert consensus on deucravacitinib for plaque psoriasis.
Readers will also discover updates on non-surgical approaches to dermatochalasis, the role of dupilumab in lichenification across diverse patient populations, and advancements in over-the-counter acne treatments featuring beta-hydroxy acids. Plus, an in-depth review on sunscreen safety and efficacy aims to dispel myths and reinforce best practices in photoprotection.
Stay ahead with the latest research shaping the future of dermatologic care—dive into the JDD February 2025 issue today!
Comparing Adherence, Side Effects, and Satisfaction in Oral and Topical Minoxidil: A Cross-Sectional Study suggest that oral minoxidil is superior to topical in terms of ease of use, adherence, and satisfaction without increasing systemic side effects.
Antioxidant, Keratolytic, and Hydrating Treatment for Seborrheic Keratoses seeks to determine an effective topical formula to improve the appearance of seborrheic keratosis and test the formula in a pilot observational study on a small number of patients.
Efficacy and Consumer Perception of Topical Over-the-Counter Regimens Involving Beta-Hydroxy Acid for Acne Vulgaris encompasses both objective clinical assessments of facial skin health and subjective reports of product tolerability, complemented by before-and-after images and questionnaires.
Insights Into Demographics, Comorbidities, and Risk Factors in Keloids and Hypertrophic Scars: A Retrospective Study utilizes the TriNetX global health research network database, analyzing and sharing the data of 6,249 patients with hypertrophic scars or keloids.
Sunscreens: Mechanisms and Safety in Depth discusses the mechanisms of action, efficacy, and safety concerns related to sunscreen use, aiming to clarify current understandings and dispel prevalent myths.
Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups analyzes and presents data from 5 clinical trials of dupilumab, including 1,997 patients aged 6 to 88 years of all races with moderate to severe AD.
A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus Panel showcases crafted consensus statements created by a panel of 10 expert dermatologists regarding the efficacy, safety, and recommended laboratory monitoring for deucravacitinib.
Non-Surgical Correction of Dermatochalasis Using Microplasma presents pre-clinical and clinical data showing the safety and effectiveness of the Alma Lasers Opus Microplasma Radiofrequency (RF) treatment using a Colibri tip.
Keloidal Morphea: A Unique Variant of Morphea Presenting in a Black Female stressed the need for Increased awareness and recognition of keloidal morphea can help prevent dermatologic health disparities, which disproportionately occur in patients of color.
Find more JDD Issue Highlights here.
